OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Natural products targeting mitochondria: emerging therapeutics for age-associated neurological disorders
Zhibin Liang, António Currais, David Soriano‐Castell, et al.
Pharmacology & Therapeutics (2020) Vol. 221, pp. 107749-107749
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Targeting Mitochondrial Biogenesis with Polyphenol Compounds
Leila Chodari, Mutlu Dilsiz Aytemir, Parviz Vahedi, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 134

Insights on functionalized carbon nanotubes for cancer theranostics
Lu Tang, Qiaqia Xiao, Yijun Mei, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 115

The Interplay Between Endoplasmic Reticulum Stress and Ferroptosis in Neurological Diseases
Tianyu Zhai, Bingbing Wang, Caizhen Shi, et al.
Neurochemical Research (2025) Vol. 50, Iss. 2
Closed Access | Times Cited: 1

Pharmacological approaches to enhance mitochondrial biogenesis: focus on PGC-1Α, AMPK, and SIRT1 in cellular health
Ahmet Alperen Palabiyik, Esra Palabıyık
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access | Times Cited: 1

Urolithin A protects dopaminergic neurons in experimental models of Parkinson's disease by promoting mitochondrial biogenesis through the SIRT1/PGC-1α signaling pathway
Jia Liu, Jingjing Jiang, Jingru Qiu, et al.
Food & Function (2021) Vol. 13, Iss. 1, pp. 375-385
Closed Access | Times Cited: 44

Ferulic acid-loaded polymeric nanoparticles prepared from nano-emulsion templates facilitate internalisation across the blood–brain barrier in model membranes
Luna Garcia, Sujey Palma-Florez, V. Espinosa, et al.
Nanoscale (2023) Vol. 15, Iss. 17, pp. 7929-7944
Open Access | Times Cited: 19

Bile acid metabolism in health and ageing-related diseases
Xiaojun Li, Chu Fang, Ruihua Zhao, et al.
Biochemical Pharmacology (2024) Vol. 225, pp. 116313-116313
Closed Access | Times Cited: 7

The potential of therapeutic strategies targeting mitochondrial biogenesis for the treatment of insulin resistance and type 2 diabetes mellitus
Wenwen Ding, Xiaoxue Yang, Kaiyi Lai, et al.
Archives of Pharmacal Research (2024) Vol. 47, Iss. 3, pp. 219-248
Closed Access | Times Cited: 6

Cannabinol inhibits oxytosis/ferroptosis by directly targeting mitochondria independently of cannabinoid receptors
Zhibin Liang, David Soriano‐Castell, Devin Kepchia, et al.
Free Radical Biology and Medicine (2022) Vol. 180, pp. 33-51
Open Access | Times Cited: 23

Carbon nanotubes: A review on synthesis and drug delivery for cancer treatment
Mohammed Faiad Naief, Samar Naser Mohammed, Ahmed Mishaal Mohammed
Inorganic Chemistry Communications (2023) Vol. 159, pp. 111694-111694
Closed Access | Times Cited: 16

The multifaceted roles of natural products in mitochondrial dysfunction
Qianrun Chen, Danhua Ruan, Jiayan Shi, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 13

Mitochondrial targeted antioxidants as potential therapy for huntington’s disease
Shubham Upadhayay, Puneet Kumar
Pharmacological Reports (2024) Vol. 76, Iss. 4, pp. 693-713
Closed Access | Times Cited: 5

Resveratrol-based compounds and neurodegeneration: Recent insight in multitarget therapy
Marialuigia Fantacuzzi, Rosa Amoroso, Simone Carradori, et al.
European Journal of Medicinal Chemistry (2022) Vol. 233, pp. 114242-114242
Closed Access | Times Cited: 22

The key roles of organelles and ferroptosis in Alzheimerʼs disease
Hui‐Zhi Long, Yan Cheng, Ziwei Zhou, et al.
Journal of Neuroscience Research (2022) Vol. 100, Iss. 6, pp. 1257-1280
Closed Access | Times Cited: 19

Vitamin B12 Ameliorates the Pathological Phenotypes of Multiple Parkinson’s Disease Models by Alleviating Oxidative Stress
Yue Wu, Zhongting Zhao, Naidi Yang, et al.
Antioxidants (2023) Vol. 12, Iss. 1, pp. 153-153
Open Access | Times Cited: 11

Fragment-based drug discovery and biological evaluation of novel cannabinol-based inhibitors of oxytosis/ferroptosis for neurological disorders
Zhibin Liang, Alec Candib, David Soriano‐Castell, et al.
Redox Biology (2024) Vol. 72, pp. 103138-103138
Open Access | Times Cited: 4

Energy Metabolism and Brain Aging: Strategies to Delay Neuronal Degeneration
Donghui Na, Z. Zhang, Meng Meng, et al.
Cellular and Molecular Neurobiology (2025) Vol. 45, Iss. 1
Open Access

Molecular mechanisms of ferroptosis and its antitumor applications in natural products
Dianping Yu, Qun Wang, Qing Zhang, et al.
Acta Biochimica et Biophysica Sinica (2023) Vol. 55, Iss. 9, pp. 1337-1347
Open Access | Times Cited: 10

Neuroprotective Strategies for Stroke by Natural Products: Advances and Perspectives
Aifen Liu, Jingyan Hu, Tzu‐Shao Yeh, et al.
Current Neuropharmacology (2023) Vol. 21, Iss. 11, pp. 2283-2309
Open Access | Times Cited: 10

Role of melatonin and quercetin as countermeasures to the mitochondrial dysfunction induced by titanium dioxide nanoparticles
Nandini Nalika, Mohammad Waseem, Pooja Kaushik, et al.
Life Sciences (2023) Vol. 328, pp. 121403-121403
Closed Access | Times Cited: 9

Carbon Nanotubes: A Targeted Drug Delivery against Cancer Cell
Prashant Kumar, Surya Nath Pandey, Farman Ahmad, et al.
Current Nanoscience (2023) Vol. 20, Iss. 6, pp. 769-800
Closed Access | Times Cited: 9

Inhibitory Role of L-theanine, a Structural Analogue of Glutamate, against GluR5 Kainate Receptor and its Prospective Utility against Excitotoxicity
Satarupa Deb, Anupom Borah
Central Nervous System Agents in Medicinal Chemistry (2024) Vol. 24, Iss. 3, pp. 317-327
Closed Access | Times Cited: 3

Potential therapeutic natural compounds for the treatment of Alzheimer's disease
Qihui Huang, Weihao Wu, Yuxi Wen, et al.
Phytomedicine (2024) Vol. 132, pp. 155822-155822
Closed Access | Times Cited: 3

Page 1 - Next Page

Scroll to top